Get Premium to unlock powerful stock data
NAS:EYEN (USA)  
Eyenovia Inc logo

Eyenovia Inc

$ 1.82 +0.07 (+4%) 10:08 PM EST
P/E:
At Loss
P/B:
1.94
Market Cap:
$ 61.09M
Enterprise V:
$ 42.12M
Volume:
232.85K
Avg Vol (2M):
139.14K
Volume:
232.85K
Market Cap $:
61.09M
PE Ratio:
At Loss
Avg Vol (2-Month):
139.14K
Enterprise Value $:
42.12M
PB Ratio:
1.94
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Eyenovia Inc
NAICS : 325412 SIC : 2834
295 Madison Avenue, Suite 2400, New York, NY, USA, 10017
Description
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
Name Current Vs Industry Vs History
Cash-To-Debt 3.45
Equity-to-Asset 0.74
Debt-to-Equity 0.26
Debt-to-EBITDA -0.55
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.14
Distress
Grey
Safe
Beneish M-Score 18.93
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 52.24
9-Day RSI 41.02
14-Day RSI 38.02
6-1 Month Momentum % -47.57
12-1 Month Momentum % -60.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.93
Quick Ratio 2.93
Cash Ratio 2.57
Days Payable 758.93

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -35.3

Financials (Next Earnings Date:2022-08-11 Est.)

EYEN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:EYEN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 12
EPS (TTM) ($) -0.54
Beta 2.24
Volatility % 54.44
14-Day RSI 38.02
14-Day ATR ($) 0.171993
20-Day SMA ($) 1.987
12-1 Month Momentum % -60.44
52-Week Range ($) 1.61 - 6.63
Shares Outstanding (Mil) 33.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Eyenovia Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More